IDIX (MM)

Idenix Pharmaceuticals to Present at the Goldman Sachs Global Healthcare Conference CAMBRIDGE, Mass., June 7 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that Jean-Pierre Sommadossi, Ph.D., Idenix's chairman and chief executive officer, will present a corporate overview at the upcoming Goldman Sachs Twenty-Sixth Annual Global Healthcare Conference on Tuesday, June 14, 2005 at 2:00 p.m. PT at the Ritz Carlton Laguna Niguel, Dana Point, CA. The live and archived webcast of the Goldman Sachs presentation can be accessed at http://customer.talkpoint.com/GOLD006/061305a_mk/default.asp?entity=idenix or under "Events" in the Idenix Investor Center at http://www.idenix.com/. The archived replay will be available on the Idenix website for two weeks following the presentation. About Idenix: Idenix Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by hepatitis B virus, hepatitis C virus and human immunodeficiency virus (HIV). Idenix's headquarters are located in Cambridge, Massachusetts and it has drug discovery operations in Montpellier, France and Cagliari, Italy. Contact: Idenix Pharmaceuticals, Inc. Media: Teri Dahlman (617) 995-9905 Investors: Amy Sullivan (617) 995-9838 DATASOURCE: Idenix Pharmaceuticals, Inc. CONTACT: Teri Dahlman, Media, +1-617-995-9905, or Amy Sullivan, Investors, +1-617-995-9838, both of Idenix Pharmaceuticals, Inc. Web site: http://www.idenix.com/

Copyright